DocGo (NASDAQ:DCGO) Releases Quarterly Earnings Results, Misses Expectations By $1.28 EPS

DocGo (NASDAQ:DCGO) released its quarterly earnings data on Monday. The company reported ($1.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by ($1.28), FiscalAI reports. The business had revenue of $74.94 million during the quarter, compared to analyst estimates of $70.36 million. DocGo had a negative net margin of 14.02% and a negative return on equity of 9.11%.

DocGo Stock Down 1.5%

NASDAQ DCGO traded down $0.01 during midday trading on Monday, hitting $0.65. The company had a trading volume of 2,115,019 shares, compared to its average volume of 749,155. DocGo has a fifty-two week low of $0.60 and a fifty-two week high of $2.89. The stock has a market cap of $63.33 million, a price-to-earnings ratio of -1.25 and a beta of 0.95. The firm has a fifty day simple moving average of $0.78 and a two-hundred day simple moving average of $1.04.

Institutional Investors Weigh In On DocGo

Institutional investors and hedge funds have recently bought and sold shares of the business. Neuberger Berman Group LLC bought a new stake in DocGo in the fourth quarter valued at $29,000. Cerity Partners LLC bought a new stake in DocGo during the second quarter worth about $37,000. Public Employees Retirement System of Ohio acquired a new stake in shares of DocGo during the fourth quarter worth approximately $40,000. Engineers Gate Manager LP bought a new position in shares of DocGo in the second quarter valued at approximately $52,000. Finally, Jain Global LLC acquired a new position in shares of DocGo in the 4th quarter worth approximately $70,000. Institutional investors own 56.44% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DocGo in a research report on Monday, December 29th. One analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, DocGo currently has a consensus rating of “Hold” and a consensus price target of $2.25.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.